Clinical Trial Update: Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD) [Phase 2]

View source ↗

Summary

Phase 2 long-term safety study of paricalcitol injections in chronic kidney disease patients on hemodialysis has completed and results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• Paricalcitol (Zemplar) Injection (paricalcitol)

Snippet

Sponsor: Abbott | Conditions: Secondary Hyperparathyroidism, Hemodialysis | Phase 2 | Status: COMPLETED | Results posted: 2011-04-19